Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer
暂无分享，去创建一个
A. Drilon | Keunchil Park | S. Novello | B. Solomon | J. Wolf | K. Goto | A. Sashegyi | Y. Elamin | V. Soldatenkova | E. Arriola | B. Lin | M. Pérol | H. Loong | F. Santini | Cai-cun Zhou | A. Bence | Lin | Hannah M Davis